Home
XBIT

XBIT

XBiotech Inc.

as of 12-04-2025 1:44pm EST

$2.53

$0.06

-2.51%

Stocks Health Care Pharmaceuticals and Biotechnology Nasdaq

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Chart Type:

Time Range:

Founded:	2005	Country:	United States
Employees:	N/A	City:	AUSTIN
Market Cap:	69.5M	IPO Year:	2015
Target Price:	N/A	AVG Volume (30 days):	198.0K
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.96	EPS Growth:	N/A
52 Week Low/High:	$2.09 - $7.24	Next Earning Date:	11-12-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered XBIT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 70.07%

70.07%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full XBIT Forecast & Prediction with Hourly Data

Compare XBIT vs Leading Stocks

See how XBIT stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free XBIT Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "XBIT XBiotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.